fda glp-1 compounding warning september 2025 Safe use of compounded GLP products π¨ FDA Moves to Permanently
Description
The uncontrollable neuroinflammation initiated by activated microglia elicits a prominent secondary injury cascade including demyelination, the loss of neurons, and glial accumulation around the originally injured site associated with irreversible neurological functional disorders [5]
These drugs lower blood sugar levels and promote weight loss, so they're widely prescribed for effective treatment of type 2 diabetes and obesity

This underscores the importance of a carefully managed discontinuation plan, which is yet to be standardized in clinical guidelines

This effect was achieved by reversing myelin damage and ameliorating degenerative changes in the sciatic nerve of diabetic rats [82]
